CONCORD
Start SIP
Invest Now
Start SIP in CONCORD
Concord Drugs live price: ₹74.9.
Concord Drugs Performance
- Today's Low
- ₹0
- Today's High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
- 50 DMA₹77.45
- 100 DMA₹75.58
- 200 DMA₹67.93
Investment Returns
- Over 1 Month -12.02%
- Over 3 Month -8.66%
- Over 6 Month + 9.26%
- Over 1 Year + 120.04%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
Current Price
₹74.90
+
2.69
(3.73%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹75.69
- 50 Day
- ₹77.45
- 100 Day
- ₹75.58
- 200 Day
- ₹67.93
Resistance and Support
74.01
- R3 78.62
- R2 76.81
- R1 75.82
- S1 73.02
- S2 71.21
- S3 70.22
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-14 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-07-03 | Preferential issue of shares | |
| 2025-06-27 | Preferential Issue of shares & Others | Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters. |
Concord Drugs F&O
About Concord Drugs
- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- Chairman & Managing Director
- Mr. Sudhir Vaid
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Popular Stocks
TCS Share PriceIRFC Share PriceIREDA Share PriceIRCTC Share PriceITC Share PriceWipro Share PriceSuzlon Share PriceTata Steel Share PriceYes Bank Share PriceHDFC Share PriceTata Power Share PriceInfosys Share PriceTata Motors Share PriceAdani Power Share PriceNHPC Share PriceRVNL Share PriceVedanta Share PricePaytm Share PriceLIC Share PriceBHEL Share Price
Concord Drugs FAQs
Concord Drugs share price is ₹74 As on 18 March, 2026 | 22:30
The Market Cap of Concord Drugs is ₹98.7 Cr As on 18 March, 2026 | 22:30
The P/E ratio of Concord Drugs is 174.4 As on 18 March, 2026 | 22:30
The PB ratio of Concord Drugs is 2.6 As on 18 March, 2026 | 22:30
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.